{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:52:36Z","timestamp":1785372756887,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.crad.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T16:45:19Z","timestamp":1497285919000},"page":"801-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Imaging features of myeloproliferative neoplasms"],"prefix":"10.1016","volume":"72","author":[{"given":"I.G.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Raso-Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2017.05.014_bib1","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.crad.2017.05.014_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.crad.2017.05.014_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythaemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2017.05.014_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2017.05.014_bib5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2017.05.014_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.crad.2017.05.014_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.blre.2011.06.002","article-title":"JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspective","volume":"25","author":"Tefferi","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.crad.2017.05.014_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000358580","article-title":"Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond","volume":"133","author":"Michiels","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PPO.0000000000000013","article-title":"Genetics of myeloproliferative neoplasms","volume":"20","author":"Viny","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.crad.2017.05.014_bib10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.hoc.2012.07.003","article-title":"Genotype\u2013phenotype interactions in the myeloproliferative neoplasms","volume":"26","author":"Godfrey","year":"2012","journal-title":"Haematol Oncol Clin North Am"},{"key":"10.1016\/j.crad.2017.05.014_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/536062","article-title":"Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies","volume":"2011","author":"Bleeker","year":"2011","journal-title":"Thrombosis"},{"key":"10.1016\/j.crad.2017.05.014_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.crad.2017.05.014_bib13","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd\u2013Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.crad.2017.05.014_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2012.09249.x","article-title":"Guidelines on the investigation and management of venous thrombosis at unusual sites","volume":"159","author":"Tait","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/2152-7806.113651","article-title":"Cerebral venous sinus thrombosis complicated by subdural haematomas: case series and literature review","volume":"4","author":"Akins","year":"2013","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.crad.2017.05.014_bib16","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/liv.12816","article-title":"Long-term outcome of liver transplant patients with Budd\u2013Chiari syndrome secondary to myeloproliferative neoplasms","volume":"35","author":"Potthoff","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.crad.2017.05.014_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.12461","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms","volume":"162","author":"Sekhar","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.crad.2017.05.014_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/506136","article-title":"Splanchnic vein thrombosis: etiology, diagnosis, and treatment","volume":"2015","author":"Qi","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.crad.2017.05.014_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mayocp.2013.01.012","article-title":"Mesenteric venous thrombosis","volume":"88","author":"Singal","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.crad.2017.05.014_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.013","article-title":"An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythaemia","volume":"23","author":"Adam","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.crad.2017.05.014_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib23","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2214\/AJR.11.7420","article-title":"MRI of spinal bone marrow: part 2, T1-weighted imaging-based differential diagnosis","volume":"197","author":"Hanrahan","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2017.05.014_bib24","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1148\/rg.317115093","article-title":"Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis","volume":"31","author":"Ihde","year":"2011","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2017.05.014_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbmt.2006.07.008","article-title":"Regression of myelofibrosis and osteosclerosis following haematopoietic cell transplantation assessed by magnetic resonance imaging and histologic grading","volume":"12","author":"Sale","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.crad.2017.05.014_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.sult.2013.12.001","article-title":"Extramedullary hemopoiesis","volume":"35","author":"Orphanidou-Vlachou","year":"2014","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.crad.2017.05.014_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOH.0000000000000017","article-title":"Pathogenesis and management of acute myeloid leukaemia that has evolved from a myeloproliferative neoplasm","volume":"21","author":"Rampal","year":"2014","journal-title":"Curr Opin Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib28","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2017.05.014_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukaemia"},{"key":"10.1016\/j.crad.2017.05.014_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/NXLCJ1B16YDFQWND","article-title":"Myeloid sarcoma involving the testis","volume":"124","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crad.2017.05.014_bib31","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/jcm4051102","article-title":"Intracranial CNS manifestations of myeloid sarcoma in patients with acute myeloid leukaemia: review of the literature and three case reports from the author's institution","volume":"4","author":"Cervantes","year":"2015","journal-title":"J Clin Med"},{"key":"10.1016\/j.crad.2017.05.014_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni","year":"2011","journal-title":"Ther Adv Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1148\/rg.296095511","article-title":"MR imaging findings of iron overload","volume":"29","author":"Queiroz-Andrade","year":"2009","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2017.05.014_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ajh.24098","article-title":"Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls","volume":"90","author":"Anderson","year":"2015","journal-title":"Am J Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1478-3231.2006.01269.x","article-title":"Consensus on extra-hepatic portal vein obstruction","volume":"26","author":"Sarin","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.crad.2017.05.014_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.crad.2017.05.014_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.24221","article-title":"Myeloproliferative neoplasms: a decade of discoveries and treatment advances","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am J Haematol"},{"key":"10.1016\/j.crad.2017.05.014_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1409002","article-title":"Ruxolitinib versus standard therapy for the treatment of polycythaemia vera","volume":"372","author":"Vannucchi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2017.05.014_bib40","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","article-title":"JAK2V617F mutation for the early diagnosis of Ph\u2013 myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","volume":"113","author":"Dentali","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.crad.2017.05.014_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017302064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017302064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:34:52Z","timestamp":1757867692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926017302064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0009926017302064"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2017.05.014","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging features of myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}